EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer

Claudia von Arx, Pietro De Placido, Aldo Caltavituro, Rossana Di Rienzo, Roberto Buonaiuto, Michelino De Laurentiis, Grazia Arpino, Fabio Puglisi, Mario Giuliano, Lucia Del Mastro

Cancer Treatment Reviews · 2023-02 · 113 · 102500

DOI: 10.1016/j.ctrv.2022.102500 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2023-02. Verfasst von Claudia von Arx und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: claudia.vonarx@ist…. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Immunoconjugates. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAntineoplastic AgentsImmunoconjugatesHumansFemaleAntibodies, Monoclonal, HumanizedTrastuzumabAdo-Trastuzumab EmtansineErb-b2 Receptor Tyrosine KinasesAntibodies, Monoclonal

Stichwörter der Autor:innen

ADCsColon-rectal cancerGastric cancerHER2-low breast cancerNon-small-cell lung cancerTrastuzumab

Substanzen

Antibodies, Monoclonal, HumanizedTrastuzumabAdo-Trastuzumab EmtansineErb-b2 Receptor Tyrosine KinasesAntineoplastic AgentsAntibodies, MonoclonalImmunoconjugates

Autor:innen und Institutionen

  • Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: claudia.vonarx@istitutotumori.na.it.
  • Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
  • Department of Medical Oncology, Unit of Medical Oncology and Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy; Department of Medicine (DAME), University of Udine, Udine, Italy.
  • Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy.

Zitieren

APA

von Arx, C., De Placido, P., Caltavituro, A., Di Rienzo, R., Buonaiuto, R., De Laurentiis, M., Arpino, G., Puglisi, F., Giuliano, M., & Del Mastro, L. (2023). The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer. Cancer Treatment Reviews, 113, 102500. https://doi.org/10.1016/j.ctrv.2022.102500

Vancouver

von Arx C, De Placido P, Caltavituro A, Di Rienzo R, Buonaiuto R, De Laurentiis M, et al. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer. Cancer Treatment Reviews. 2023;113:102500. doi:10.1016/j.ctrv.2022.102500

BibTeX
@article{vonArx2023,
  author = {von Arx, Claudia and De Placido, Pietro and Caltavituro, Aldo and Di Rienzo, Rossana and Buonaiuto, Roberto and De Laurentiis, Michelino and Arpino, Grazia and Puglisi, Fabio and Giuliano, Mario and Del Mastro, Lucia},
  title = {The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer},
  journal = {Cancer Treatment Reviews},
  year = {2023},
  volume = {113},
  pages = {102500},
  doi = {10.1016/j.ctrv.2022.102500}
}
Kostenlos starten →